Global Glioblastoma Multiforme (GBM) Treatment Market Projected to Reach $4.06 Billion by 2029 at a CAGR of 10.5%
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Glioblastoma Multiforme (GBM) Treatment Market Size Shifted, And What Is the Outlook Through 2034?
The market size for glioblastoma multiforme (gbm) treatment has shown robust growth in the past few years. It is forecasted to expand from $2.48 billion in 2024 to $2.73 billion in 2025, experiencing a compound annual growth rate (CAGR) of 9.8%. Several factors have contributed to the growth during the historical period, including a rise in incidence and prevalence, progress in diagnostic methods, increased research funding and clinical trials, collaborations and alliances, as well as an enhanced comprehension of tumor biology.
There’s anticipated swift expansion in the glioblastoma multiforme (gbm) treatment market over the next few years, ballooning to about $4.06 billion by 2029, with a compound annual growth rate (CAGR) of 10.5%. The surge within the prediction period can be credited to the emergence of immunotherapies, advancements in precision medicine, broadened understanding of genetic indicators, advocacy and awareness initiatives for patients, and government aid for rare ailments. Key trends for the prediction period involve the examination of combination therapies, implementing artificial intelligence in diagnosis and treatment strategies, an increased acceptance of immunotherapeutic approaches, and the introduction of advanced medical tools and apparatus.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8803&type=smp
What are the Fundamental Drivers and Innovations Shaping the Glioblastoma Multiforme (GBM) Treatment Market?
The rising incidence of neurological disorders is set to accelerate the development of the market for treatments for glioblastoma multiforme (GBM). Neurological disorders encompass irregularities in the functioning of the brain, nerves throughout the body, and the spinal cord. The surge in the occurrence of such disorders, like glioblastoma multiforme (GBM), is linked to various factors; an aging population, weakened immune systems, overdiagnosis, ionizing radiation, air pollution and others. This has heightened the demand for treatments associated with these disorders to improve health and wellness. A 2022 report by the American Cancer Society, a voluntary health institution committed to overcoming cancer, revealed roughly 25,050 malignant brain or spinal cord tumors diagnosed in the US. As such, the escalating occurrence of neurological disorders bolsters the growth of the glioblastoma multiforme (GBM) treatment market.
How Is the Glioblastoma Multiforme (GBM) Treatment Market Segmented?
The glioblastoma multiforme (gbm) treatmentmarket covered in this report is segmented –
1) By Treatment: Surgery; Radiation Therapy; Chemotherapy; Targeted Therapy; Tumor Treating Field (TTF) Therapy; Immunotherapy
2) By Drug Class: Temozolomide; Bevacizumab; Lomustine; Carmustine Wafers; Other Drug Classes
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
4) By End-Use: Hospitals; Clinics; Ambulatory Surgical Centers
Subsegments:
1) By Surgery: Tumor Resection; Biopsy Procedures
2) By Radiation Therapy: External Beam Radiation Therapy (EBRT); Stereotactic Radiation Therapy
3) By Chemotherapy: Standard Chemotherapy; Combination Chemotherapy Regimens
4) By Targeted Therapy: EGFR Inhibitors; Other Targeted Agents
5) By Tumor Treating Field (TTF) Therapy: Device-Based TTF Treatment
6) By Immunotherapy: Checkpoint Inhibitors; Vaccine-Based Therapies
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8803&type=smp
Which Regions Are Driving the Next Phase of the Glioblastoma Multiforme (GBM) Treatment Market Growth?
North America was the largest region in the glioblastoma multiforme (GBM) treatment market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glioblastoma multiforme (gbm) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Glioblastoma Multiforme (GBM) Treatment Market?
Leading firms in the market are focusing on the creation of innovative portable and wearable devices to maintain their dominance in the industry. These technological advancements are designed to offer users improved functionality, comfort, and convenience, meeting the rising demand for efficient and accessible health care solutions. For example, Novocure, an oncology firm based in Jersey, unveiled Optune Gio in 2023, a wearable and portable treatment system for patients newly diagnosed with glioblastoma (GBM) that has received FDA approval. The device utilizes Tumor Treating Fields (TTFields), alternating electrical fields that hinder the division of cancer cells, potentially prolonging the patient’s life. Optune Gio, weighing just 2.7 pounds, is designed for comfort and allows patients to continue their daily activities while wearing it.
View the full report here:
How Is the Glioblastoma Multiforme (GBM) Treatment Market Defined and What Are Its Core Parameters?
Glioblastoma multiforme (GBM) treatment refers to the management and care of a patient suffering from glioblastoma multiforme, a kind of brain or spinal cord tumor that grows quickly. Adults with this primary malignant brain tumor have the highest prevalence rate.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8803
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
